{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:00:44Z","timestamp":1789556444650,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014759","name":"Medical Scientific Research Foundation of Zhejiang Province, China","doi-asserted-by":"publisher","award":["2022KY1123"],"award-info":[{"award-number":["2022KY1123"]}],"id":[{"id":"10.13039\/501100014759","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LY23H290004"],"award-info":[{"award-number":["LY23H290004"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007834","name":"Ningbo Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["2021J317"],"award-info":[{"award-number":["2021J317"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007834","name":"Ningbo Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["2022J242"],"award-info":[{"award-number":["2022J242"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ijbiomac.2025.142276","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T03:55:27Z","timestamp":1742356527000},"page":"142276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"P4","title":["Salidroside attenuates NASH through regulating bile acid-FXR\/TGR5 signaling pathway via targeting gut microbiota"],"prefix":"10.1016","volume":"307","author":[{"given":"Jun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheyun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanyang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ijbiomac.2025.142276_bb0005","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142276_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.142276_bb0015","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.142276_bb0020","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2024.5412","article-title":"Current strategies for nonalcoholic fatty liver disease treatment (review)","volume":"54","author":"Sun","year":"2024","journal-title":"Int. J. Mol. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.142276_bb0025","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1007\/s00394-022-02846-7","article-title":"Multidisciplinary lifestyle intervention is associated with improvements in liver damage and in surrogate scores of NAFLD and liver fibrosis in morbidly obese patients","volume":"61","author":"Bischoff","year":"2022","journal-title":"Eur. J. Nutr."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.142276_bb0030","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/jama.2020.22478","article-title":"Long-term complications of bariatric surgery","volume":"325","author":"Weiss","year":"2021","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142276_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.70394","article-title":"A new Hope for the patients of non-alcoholic steatohepatitis: FDA gives green signal for Resmetirom use","volume":"8","author":"Hasan","year":"2025","journal-title":"Health Sci. Rep."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.142276_bb0040","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1002\/ptr.7932","article-title":"Preventive and therapeutic effects of natural products and herbal extracts on nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"37","author":"Cao","year":"2023","journal-title":"Phytother. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142276_bb0045","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41467-020-20422-7","article-title":"Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma","volume":"12","author":"Behary","year":"2021","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.142276_bb0050","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","article-title":"The gut-liver axis and gut microbiota in health and liver disease","volume":"21","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.142276_bb0055","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.142276_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.advnut.2024.100362","article-title":"Gut microbiota: an important participant in childhood obesity","volume":"16","author":"Luo","year":"2025","journal-title":"Adv. Nutr."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.142276_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111358","article-title":"Why bile acids are so important in Non-Alcoholic Fatty Liver Disease (NAFLD) progression","volume":"8","author":"Gottlieb","year":"2019","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.142276_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102530","article-title":"The role of FXR and TGR5 in reversing and preventing progression of Western diet-induced hepatic steatosis, inflammation, and fibrosis in mice","volume":"298","author":"Wang","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.142276_bb0075","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijbiomac.2025.142276_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116462","article-title":"Update on the development of TGR5 agonists for human diseases","volume":"271","author":"Jin","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142276_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154733","article-title":"Jiang-Tang-San-Huang pill alleviates type 2 diabetes mellitus through modulating the gut microbiota and bile acids metabolism","volume":"113","author":"Tawulie","year":"2023","journal-title":"Phytomedicine"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.142276_bb0090","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.molmed.2015.09.001","article-title":"Bile acid-activated receptors, intestinal microbiota, and the treatment of metabolic disorders","volume":"21","author":"Fiorucci","year":"2015","journal-title":"Trends Mol. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.142276_bb0095","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1053\/j.gastro.2016.08.057","article-title":"An intestinal microbiota-Farnesoid X receptor axis modulates metabolic disease","volume":"151","author":"Gonzalez","year":"2016","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.142276_bb0100","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ptr.7636","article-title":"Salidroside alleviates ulcerative colitis via inhibiting macrophage pyroptosis and repairing the dysbacteriosis-associated Th17\/Treg imbalance","volume":"37","author":"Liu","year":"2023","journal-title":"Phytother. Res."},{"key":"10.1016\/j.ijbiomac.2025.142276_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121793","article-title":"Salidroside alleviates acetaminophen-induced hepatotoxicity via Sirt1-mediated activation of Akt\/Nrf2 pathway and suppression of NF-\u03baB\/NLRP3 inflammasome axis","volume":"327","author":"Gao","year":"2023","journal-title":"Life Sci."},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.142276_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/nu16152387","article-title":"Salidroside: a promising agent in bone metabolism modulation","volume":"16","author":"Wojdasiewicz","year":"2024","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.142276_bb0115","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1002\/hep.32066","article-title":"Salidroside activates the AMP-activated protein kinase pathway to suppress nonalcoholic steatohepatitis in mice","volume":"74","author":"Hu","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ijbiomac.2025.142276_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155505","article-title":"A promising therapy for fatty liver disease: PCSK9 inhibitors","volume":"128","author":"Han","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijbiomac.2025.142276_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109915","article-title":"Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota-bile acid-farnesoid X receptor axis","volume":"124","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142276_bb0130","doi-asserted-by":"crossref","first-page":"eaax6208","DOI":"10.1126\/sciadv.aax6208","article-title":"Citrus polymethoxyflavones attenuate metabolic syndrome by regulating gut microbiome and amino acid metabolism","volume":"6","author":"Zeng","year":"2020","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.142276_bb0135","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.142276_bb0140","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216928","article-title":"Microbial metabolites in chronic heart failure and its common comorbidities","volume":"15","author":"Hua","year":"2023","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142276_bb0145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","article-title":"Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH)","volume":"7","author":"Xu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2025.142276_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.120197","article-title":"\u03b1-D-1,3-glucan from Radix Puerariae thomsonii improves NAFLD by regulating the intestinal flora and metabolites","volume":"299","author":"Li","year":"2023","journal-title":"Carbohydr. Polym."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.142276_bb0155","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH","volume":"11","author":"Kolodziejczyk","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.142276_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106621","article-title":"Diosgenin alleviates nonalcoholic steatohepatitis through affecting liver-gut circulation","volume":"187","author":"Yan","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijbiomac.2025.142276_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155847","article-title":"Hypericum perforatum L. attenuates depression by regulating Akkermansia muciniphila, tryptophan metabolism and NF\u03baB-NLRP2-Caspase1-IL1\u03b2 pathway","volume":"132","author":"Jiang","year":"2024","journal-title":"Phytomedicine"},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.142276_bb0170","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.scib.2023.06.027","article-title":"Sinomenine ameliorates rheumatoid arthritis by modulating tryptophan metabolism and activating aryl hydrocarbon receptor via gut microbiota regulation","volume":"68","author":"Jiang","year":"2023","journal-title":"Sci. Bull. (Beijing)"},{"key":"10.1016\/j.ijbiomac.2025.142276_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154937","article-title":"Aqueous extract of Polygala japonica Houtt. ameliorated nonalcoholic steatohepatitis in mice through restoring the gut microbiota disorders and affecting the metabolites in feces and liver","volume":"118","author":"Liao","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijbiomac.2025.142276_bb0180","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.nutres.2019.07.001","article-title":"Gnotobiotic mice inoculated with Firmicutes, but not Bacteroidetes, deteriorate nonalcoholic fatty liver disease severity by modulating hepatic lipid metabolism","volume":"69","author":"Chen","year":"2019","journal-title":"Nutr. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142276_bb0185","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s40168-021-01125-7","article-title":"Commensal microbe-derived acetate suppresses NAFLD\/NASH development via hepatic FFAR2 signalling in mice","volume":"9","author":"Aoki","year":"2021","journal-title":"Microbiome"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.142276_bb0190","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4161\/gmic.25723","article-title":"Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship","volume":"4","author":"Ridlon","year":"2013","journal-title":"Gut Microbes"},{"issue":"36","key":"10.1016\/j.ijbiomac.2025.142276_bb0195","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0804437105","article-title":"Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome","volume":"105","author":"Jones","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2025.142276_bb0200","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pharmthera.2018.04.005","article-title":"Bile acid regulation: a novel therapeutic strategy in non-alcoholic fatty liver disease","volume":"190","author":"Yu","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142276_bb0205","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","article-title":"Consequences of bile salt biotransformations by intestinal bacteria","volume":"7","author":"Ridlon","year":"2016","journal-title":"Gut Microbes"},{"key":"10.1016\/j.ijbiomac.2025.142276_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118526","article-title":"Integrated serum metabolomics, 16S rRNA sequencing and bile acid profiling to reveal the potential mechanism of gentiopicroside against nonalcoholic steatohepatitis in lean mice","volume":"334","author":"Li","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ijbiomac.2025.142276_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155919","article-title":"Yellow tea polysaccharides protect against non-alcoholic fatty liver disease via regulation of gut microbiota and bile acid metabolism in mice","volume":"133","author":"Huang","year":"2024","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.142276_bb0220","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/s41401-021-00849-4","article-title":"FXR: structures, biology, and drug development for NASH and fibrosis diseases","volume":"43","author":"Tian","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.142276_bb0225","doi-asserted-by":"crossref","first-page":"152","DOI":"10.21037\/hbsn.2019.09.03","article-title":"Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease","volume":"9","author":"Li","year":"2020","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"10.1016\/j.ijbiomac.2025.142276_bb0230","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.2147\/DDDT.S170518","article-title":"Farnesoid X receptor agonist INT-767 attenuates liver steatosis and inflammation in rat model of nonalcoholic steatohepatitis","volume":"12","author":"Hu","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ijbiomac.2025.142276_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115333","article-title":"Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice","volume":"294","author":"Li","year":"2022","journal-title":"J. Ethnopharmacol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025028284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025028284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:29:08Z","timestamp":1782876548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025028284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":47,"alternative-id":["S0141813025028284"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142276","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salidroside attenuates NASH through regulating bile acid-FXR\/TGR5 signaling pathway via targeting gut microbiota","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142276","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"142276"}}